E-Paper
Dr Reddy's Lab Q2 profit up 69% at Rs 690 crore
Drug major Dr Reddy's Laboratories on Thursday reported a 69.41% increase in consolidated net profit at Rs 690.25 crore for the second quarter ended September 30.
Updated on: Oct 31, 2013, 15:41:48 IST
Share via
Copy link
Drug major Dr Reddy's Laboratories on Thursday reported a 69.41% increase in consolidated net profit at Rs 690.25 crore for the second quarter ended September 30.
The company had posted a profit of Rs 407.44 crore in the same period of the previous financial year.
Net sales rose to Rs 3,357.45 crore from Rs 2,880.85 crore a year earlier, Dr Reddy's Laboratories said in a BSE filing. Revenue from the global generics segment grew 32% to Rs 2,654.78 crore, driven by North America, Russia and other emerging markets, the company said.
Shares of Dr Reddy's Laboratories were down 2.52% at Rs 2,459.20 on the BSE in late afternoon trade.
Stay updated with the latest Business News, stock market updates, petrol and diesel prices, gold and silver rates, income tax updates and major developments from India and across the world.
